Additive effect of pretransplant obesity, diabetes, and cardiovascular risk factors on outcomes after liver transplantation

Liver Transplantation

Volumn 20, Issue 3, 2014, Pages 281-290

  Dare, Anna J ^a   Plank, Lindsay D ^a   Phillips, Anthony R J ^a,c   Gane, Edward J ^c   Harrison, Barry ^c   Orr, David ^c   Jiang, Yannan ^b   Bartlett, Adam S J R ^a,c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY FAT; BODY MASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DUAL ENERGY X RAY ABSORPTIOMETRY; END STAGE LIVER DISEASE; ETHNICITY; FEMALE; HUMAN; HYPERTENSION; LENGTH OF STAY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OBESITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; END STAGE LIVER DISEASE; FEMALE; FIBROSIS; HEPATITIS C; HUMANS; LENGTH OF STAY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEW ZEALAND; OBESITY; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896694776     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23818     Document Type: Article

References (33)

1. Alberti KG, Zimmet P, Shaw J,; for IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-1062.
2. Zimmet P, Alberti KG, Shaw J,. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787.
3. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, et al.; for Lancet NCD Action Group and NCD Alliance. Priority actions for the non-communicable disease crisis. Lancet 2011; 377: 1438-1447.
4. Flancbaum L, Choban PS,. Surgical implications of obesity. Annu Rev Med 1998; 49: 215-234.
5. Choban PS, Flancbaum L,. The impact of obesity on surgical outcomes: a review. J Am Coll Surg 1997; 185: 593-603.
6. Mullen JT, Moorman DW, Davenport DL,. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 2009; 250: 166-172.
7. Campbell D,. Doctors back denial of treatment for smokers and the obese. http://www.theguardian.com/society/2012/apr/28/doctors-treatment-denial-smokers- obese. Published April 28, 2012. Accessed November 2013.
8. Leonard J, Heimbach JK, Malinchoc M, Watt K, Charlton M,. The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database. Am J Transplant 2008; 8: 667-672.
9. Watt KDS,. Obesity and metabolic complications of liver transplantation. Liver Transpl 2010; 16 (suppl 2): S65-S71.
10. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163.
11. Rush EC, Freitas I, Plank LD,. Body size, body composition and fat distribution: comparative analysis of European, Maori, Pacific Island and Asian Indian adults. Br J Nutr 2009; 102: 632-641.
12. John PR, Thuluvath PJ,. Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transpl 2002; 8: 708-713.
13. Laryea M, Watt KD, Molinari M, Walsh MJ, McAlister VC, Marotta PJ, et al. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Liver Transpl 2007; 13: 1109-1114.
14. Vogt DP, Henderson JM, Carey WD, Barnes D,. The long-term survival and causes of death in patients who survive at least 1 year after liver transplantation. Surgery 2002; 132: 775-780.
15. Sato H, Carvalho G, Sato T, Lattermann R, Matsukawa T, Schricker T,. The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgery. J Clin Endocrinol Metab 2010; 95: 4338-4344.
16. Shoelson SE, Herrero L, Naaz A,. Obesity, inflammation, and insulin resistance. Gastroenterology 2007; 132: 2169-2180.
17. Hotamisligil GS,. Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
18. Slynkova K, Mannino DM, Martin GS, Morehead RS, Doherty DE,. The role of body mass index and diabetes in the development of acute organ failure and subsequent mortality in an observational cohort. Crit Care 2006; 10: R137.
19. Hill GL, Monk D, Plank LD,. Measuring body composition in intensive care patients. In:, Wilmore DW, Carpenter YA, eds. Metabolic Support of the Critically Ill Patient. Berlin, Germany: Springer; 1993: 3-18. Update in Intensive Care and Emergency Medicine; vol 17.
20. World Health Organization. BMI classification. http://apps.who.int/bmi/ index.jsp?introPage=intro-3.html. Accessed November 2013.
21. Dindo D, Demartines N, Clavien PA,. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213.
22. Nair S, Vanatta JM, Arteh J, Eason JD,. Effects of obesity, diabetes, and prior abdominal surgery on resource utilization in liver transplantation: a single-center study. Liver Transpl 2009; 15: 1519-1524.
23. Keeffe EB, Gettys C, Esquivel CO,. Liver transplantation in patients with severe obesity. Transplantation 1994; 57: 309-311.
24. Nair S, Verma S, Thuluvath PJ,. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology 2002; 35: 105-109.
25. Dick AA, Spitzer AL, Seifert CF, Deckert A, Carithers RL Jr, Reyes JD, Perkins JD,. Liver transplantation at the extremes of the body mass index. Liver Transpl 2009; 15: 968-977.
26. Yoo HY, Thuluvath PJ,. The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Transplantation 2002; 74: 1007-1012.
27. Shields PL, Tang H, Neuberger JM, Gunson BK, McMaster P, Pirenne J,. Poor outcome in patients with diabetes mellitus undergoing liver transplantation. Transplantation 1999; 68: 530-535.
28. Blanco JJ, Herrero JI, Quiroga J, Sangro B, Gõmez-Manero N, Pardo F, et al. Liver transplantation in cirrhotic patients with diabetes mellitus: midterm results, survival, and adverse events. Liver Transpl 2001; 7: 226-233.
29. Trail KC, Stratta RJ, Larsen JL, Ruby EI, Patil KD, Langnas AN, et al. Results of liver transplantation in diabetic patients. Surgery 1993; 114: 650-656.
30. Navasa M, Bustamante J, Marroni C, González E, Andreu H, Esmatjes E, et al. Diabetes mellitus after liver transplantation: prevalence and predictive factors. J Hepatol 1996; 25: 64-71.
31. Canzanello VJ, Schwartz L, Taler SJ, Textor SC, Wiesner RH, Porayko MK, Krom RA,. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). Liver Transpl Surg 1997; 3: 1-9.
32. Lavanchy D,. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97-107.
33. New Zealand Ministry of Health. A Focus on Nutrition: Key Findings From the 2008/09 NZ Adult Nutrition Survey. http://www.health.govt.nz/publication/ focus-nutrition-key-findings-2008-09-nz-adult-nutrition-survey. Published September 2, 2011. Accessed November 2013.